2021
DOI: 10.1016/j.gie.2021.03.025
|View full text |Cite
|
Sign up to set email alerts
|

Transpapillary gallbladder stent placement for long-term therapy of acute cholecystitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
26
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(33 citation statements)
references
References 19 publications
2
26
0
1
Order By: Relevance
“… Forest plot showing the individual study proportions of endoscopic transpapillary gallbladder drainage related adverse events in relation to the pooled rate[ 7 , 9 , 22 , 24 - 39 ] . …”
Section: Resultsmentioning
confidence: 99%
“… Forest plot showing the individual study proportions of endoscopic transpapillary gallbladder drainage related adverse events in relation to the pooled rate[ 7 , 9 , 22 , 24 - 39 ] . …”
Section: Resultsmentioning
confidence: 99%
“…However, a recent study with a mean follow-up of 453 days did find a greater risk of recurrent cholecystitis in those individuals where the stent was removed. 27 Larger studies with longer follow-up are required to determine how long stents should be left in place in asymptomatic patients. Currently, there are no guidelines to recommend either stent removal or stent exchange.…”
Section: Endoscopic Transpapillary Gbdmentioning
confidence: 99%
“…ENGBD and EGBS are classified as transpapillary approaches; a naso-gallbladder tube is placed in ENGBD and a plastic stent extending from the gallbladder to the duodenum is placed in EGBS [ 9 ]. Since EGBS is an internal fistula method, the tube can be indwelling for a long period of time without impairing a patient’s quality of life; in fact, long-term placement can be useful in preventing cholecystitis recurrence in patients with end-stage liver disease [ 10 , 11 , 12 ] and poor surgical candidates [ 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ] ( Figure 1 ). Based on research surrounding biliary stent placement for malignant or benign biliary strictures, it is unlikely that the stent will remain patent for years [ 27 , 28 ].…”
Section: Egbs Vs Ptgbd For Long-term Outcomesmentioning
confidence: 99%